June 2014 FDA Recall Drug by Forest Pharmaceuticals Inc
D-1412-2014 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Forest Pharmaceuticals Inc on June 19, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1412-2014

Reason for Recall
Failed Dissolution Specifications: Drug failed stage III dissolution testing.
Initiated
06-19-2014
Reported
07-09-2014
Quantity
92,544 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Forest Pharmaceuticals Inc
Nationwide including Puerto Rico.
Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.

Batch or Lot Expiration Information

Lot# A308879, Expiry: 09/2015